PortfoliosLab logo

Ampio Pharmaceuticals, Inc. (AMPE)

Equity · Currency in USD · Last updated Mar 18, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Ampio Pharmaceuticals, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $106 for a total return of roughly -98.94%. All prices are adjusted for splits and dividends.

AMPE (Ampio Pharmaceuticals, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AMPE

Ampio Pharmaceuticals, Inc.


Ampio Pharmaceuticals, Inc. had a return of -4.35% year-to-date (YTD) and -96.67% in the last 12 months. Over the past 10 years, Ampio Pharmaceuticals, Inc. had an annualized return of -42.13%, while the S&P 500 had an annualized return of 9.71%, indicating that Ampio Pharmaceuticals, Inc. did not perform as well as the benchmark.

1 month-24.11%-5.31%
6 months-85.14%0.39%
1 year-96.67%-10.12%
5 years (annualized)-64.66%7.32%
10 years (annualized)-42.13%9.71%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Ampio Pharmaceuticals, Inc. Sharpe ratio is -0.62. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

AMPE (Ampio Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Dividend History

Ampio Pharmaceuticals, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

AMPE (Ampio Pharmaceuticals, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Ampio Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Ampio Pharmaceuticals, Inc. is 99.82%, recorded on Dec 21, 2022. The portfolio has not recovered from it yet.



To Bottom


To Recover



-99.82%Oct 25, 20132306Dec 21, 2022
-77.78%Apr 5, 201088Aug 6, 2010121Jan 28, 2011209
-72.14%Sep 19, 2011166May 15, 2012363Oct 24, 2013529
-68%Mar 14, 20118Mar 23, 2011121Sep 14, 2011129
-20%Feb 16, 20112Feb 17, 20112Feb 22, 20114
-14.29%Aug 1, 200897Dec 30, 2008299Mar 10, 2010396
-10.26%Mar 3, 20111Mar 3, 20113Mar 8, 20114
-6.45%Feb 28, 20111Feb 28, 20112Mar 2, 20113
-5.51%Feb 2, 20113Feb 4, 20114Feb 10, 20117

Volatility Chart

Current Ampio Pharmaceuticals, Inc. volatility is 173.27%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

AMPE (Ampio Pharmaceuticals, Inc.)
Benchmark (^GSPC)